Comparative Lipid and Lipoprotein Metabolism

Veterinary Clinical Pathology

Volumn 25, Issue 2, 1996, Pages 49-56

  Bauer, John E ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Atherogenesis; Cholesterol; Comparative; Lipid; Lipoprotein

Indexed keywords

ANIMALIA; MAMMALIA;

EID: 0347138991     PISSN: 02756382     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-165X.1996.tb00968.x     Document Type: Article

References (37)

1. Newsholme EA, Leech AR: Biochemistry for the Medical Sciences, New York, John Wiley & Sons, 1983, pp 246-299.
2. Russell DW: Cholesterol Biosynthesis and Metabolism. Cardiovasc Drug Ther 6:103-110, 1992.
3. Schenck PA: Mechanisms of the Variable Response to Dietary Cholesterol. PhD Dissertation, University of Florida, 1991.
4. Chapman MJ: Comparative Analysis of Mammalian Plasma Lipoproteins. Meth Enz 128:70-143, 1986.
5. Overturf ML, Loose-Mitchell DS: in vivo Model Systems: The Choice of the Experimental Animal Model for Analysis of Lipoproteins and Atherosclerosis. Current Opin Lipidol 3:179-185, 1992.
6. Watson TDG, Bums L, Love S, et al: The Isolation, Characterization and Quantification of the Equine Plasma Lipoproteins. Eq Vet J 23:353-359, 1991.
7. Bauer JE: Plasma Lipids and Lipoproteins of Fasting Ponies. Am J Vet Res 44:379-384, 1983.
8. Havel RJ: Uptake and Processing of Remnants of Chylomicrons and Very Low Density Lipoproteins by Rat Liver. J Lipid Res 25:1151-1158, 1984.
9. Stalenhoef AFH, Malloy MJ, Kane JP, et al: Metabolism of Apolipoproteins B-48 and B-100 of Triglyceride-Rich Lipoproteins of Normal and Lipoprotein Lipase Deficient Subjects. Proc Natl Acad Sci USA 81:1839-1843, 1984.
10. Packard CJ, Munro A, Lorimer AR, et al: Metabolism of Apolipoprotein B in Large Triglyceride-Rich Very Low Density Lipoproteins of Normal and Hypertriglyceridemic Subjects. J Clin Invest 74:2178-2192, 1984.
11. Pagnan A, Havel RJ, Kane JP, et al: Characterization of Human Very Low Density Lipoproteins Containing Two Electrophoretic Populations: Double Pre-Betalipoproteinemia and Primary Dysbetalipoproteinemia. J Lipid Res 18:613-619, 1977.
12. Gianturco SH, Gotto Jr AM, Jackson RL, et al: Control of 3-Hydroxy-3Methylglutaryl-CoA Reductase Activity in Cultured Human Fibroblasts by Very Low Density Lipoproteins of Subjects With Hypertriglyceridemia. J Clin Invest 61:320-328, 1978.
13. Henrickskon T, Mahoney EM, Steinberg D: Enhanced Macrophage Degradation of Low Density Lipoprotein Previously Incubated With Cultured Endothelial Cells: Recognition by Receptor for Acetylated Low Density Lipoproteins. Proc Natl Acad Sci USA 78:6599-6503, 1981.
14. Yla-Herttuala S, Palinski W, Rosenfeld ME, et al: Evidence for the Presence of Oxidatively Modified Low Density Lipoprotein in Atherosclerotic Lesions of Rabbit and Man. J Clin Invest 84:1086-1095, 1989.
15. Gibbons G, Angelin B: Lipid Metabolism. Curr Opin Lipidol 5:157-159, 1994.
16. Dietschy JM, Turley SD, Spady DK: Role of Liver in the Maintenance of Cholesterol and Low Density Lipoprotein Homeostasis in Different Animal Species, Including Humans. J Lipid Res 34:1637-1659, 1993.
17. Scott J, Navaratnam N, Bhattacharya, Morrison JR: The Apolipoprotein B Messenger RNA Editing Enzyme. Curr Opin Lipdol 5:87-93, 1994.
18. Greeve J, Altkemper I, Dleterich JH, et al: Apolipoprotein-B Messenger RNA Editing in 12 Different Mammalian Species - Hepatic Expression is Reflected in Low Concentrations of ApoB-Containing Plasma Lipoproteins. J Lipid Res 34:1367-1383, 1993.
19. Hamilton RL: In: Plasma Protein Secretion by the Liver, Ed by H Glaumann, T Peters. London, Academic Press, 1984, p 357.
20. Fielding PE, Fielding CJ: Dynamics of Lipoprotein Transport System. In: Biochemistry of Lipids, Lipoproteins and Membranes. Ed by DE Vance, J Vance. NewYork, Elsevier, 1991, pp 427-461.
21. Green PHR, Glickman J: Intestinal Lipoprotein Metabolism. J Lipid Res 22:1153-1160, 1981.
22. Forester GP, Tall AP, Bisgaier CL, et al: Rat Intestine Secretes Spherical High Density Lipoproteins. J Biol Chem 258:5938-5943, 1983.
23. Gotto Jr AM, Pownall HJ, Havel RJ: Introduction to the Plasma Lipoproteins. Meth Enz 128:3-41, 1966.
24. Fielding CJ: Reverse Cholesterol Transport. Curr Opin Lipidol 2:376-378, 1991.
25. Bauer JE: Modification of Serum Phospholipid and Cholesterol Ester Molecular Species by LCAT in Polyunsaturated Fat Supplemented Dogs. Vet Path 31:580, 1994.
26. Subbaiah PV, Liu M: Influence of Long Chain Fatty Acids on the Positional Specificity of Lecithin: Cholesterol Acyl Transferase. Species Differences and Possible Relationship to Atherogenic Susceptibility. First Intl Congress, Intl Soc Study of Fatty Acids and Lipids: Fatty Acids and Lipids from Cell Biology to Disease. 1993, p 126.
27. HA, YC, Barter PJ: Differences in Plasma Cholesteryl Ester Transfer Activity in Sixteen Vertebrate Species. Comp Biochem Physiol 71B:265-269, 1992.
28. Markwell PJ: Personal Communication.
29. Mahley RW, Weisgraber KH, Innerarity T: Canine Lipoproteins and Atherosclerosis. II. Characterization of the Plasma Lipoproteins Associated With Atherogenic and Nonatherogenic Hyperlipidemia. Circ Res 35:722-733, 1973.
30. Mahley RW, Hui DY, Innerarity TL, et al: Two Independent Lipoprotein Receptors on Hepatic Membranes of Dogs, Swine, and Man. Apo-B,E and Apo-E Receptors. J Clin Invest 68:1197-1206, 1981.
31. Bauer JE: Single Spin Density Gradient Systems and Micropreparative Ultracentrifugation. In: Analyses of Fats, Lipids and Lipoproteins. Ed by ED Perkins. Champaign, Am Oil Chem Soc, 1991, pp 555-572.
32. McAlister K, Harte J, Bauer JE: Serum Lipids and Lipoproteins of Dogs Fed Dietary N-6 and N-3 Fatty Acid Supplements. Proc. 12th ACVIM Forum, 1994, San Francisco, p 998.
33. Swenson TL: Transfer Proteins in Reverse Cholesterol Transport. Curr Opin Lipidol 3:67-74, 1992.
34. Inazu A, Brown ML, Hesier CB, et al: Increased High-Density Lipoprotein Levels Caused by a Common Cholesteryl-Ester Transfer Protein Gene Mutation. N Engl J Med 323:1234-1238, 1990.
35. Bisgaier CL, Sienenkas MV, Brown ML, et al: Familial Cholesteryl Ester Transfer Protein Deficiency is Associated With Tiglyceride-Rich Low Density Lipoproteins Containing Cholesteryl Esters of Probable Cellular Origin. J Lipid Res 32:21-33, 1991.
36. Breslow JL: Lipoprotein Metabolism and Atherogenesis Susceptibility in Transgenic Mice. Curr Opin Lipidol 5:175-184, 1994.
37. Nakashima Y, Plump AS, Raines EW, et al: Apo-E Deficient Mice Develop Lesions of all Phase of Atherosclerosis Throughout the Arterial Tree. Atherscler Thromb 14:133-140, 1994.